Hypera (OTCMKTS:HYPMY) Shares Cross Above 50 Day Moving Average - Should You Sell?

Hypera S.A. (OTCMKTS:HYPMY - Get Free Report)'s share price passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $3.81 and traded as high as $4.56. Hypera shares last traded at $4.30, with a volume of 6,512 shares changing hands.

Hypera Price Performance

The company has a current ratio of 1.81, a quick ratio of 1.41 and a debt-to-equity ratio of 0.68. The company's fifty day moving average is $3.83 and its two-hundred day moving average is $3.43. The stock has a market cap of $2.88 billion, a price-to-earnings ratio of 18.96 and a beta of 0.76.

Hypera (OTCMKTS:HYPMY - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The company reported ($0.04) EPS for the quarter. Hypera had a net margin of 20.04% and a return on equity of 13.18%. The business had revenue of $184.34 million during the quarter.

About Hypera

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.